EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Advancing COVID-19 diagnostics: rapid detection of intact SARS-CoV-2 using viability RT-PCR assay

Judith M J Veugen iD, Tom Schoenmakers, Inge H M van Loo, Bart L Haagmans iD, Mathie P G Leers, Mart M Lamers iD, Mayk Lucchesi, Bas C T van Bussel, Walther N K A van Mook, Rudy M M A Nuijts, Paul H M Savelkoul, Mor M Dickman und 1 weitere

Microbiology Spectrum · 2024

DOI: 10.1128/spectrum.00160-24 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microbiology Spectrum, 2024. Verfasst von Judith M J Veugen und 12 weiteren Autor:innen. Beteiligte Einrichtung: University Eye Clinic Maastricht, Maastricht University Medical Center, Maastricht, the Netherlands. Hauptthemen laut MEDLINE: SARS-CoV-2, COVID-19, RNA, Viral, Reverse Transcriptase Polymerase Chain Reaction. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: ZonMw (Netherlands Organisation for Health Research and Development).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes coronavirus disease 2019 (COVID-19). Commonly used methods for both clinical diagnosis of SARS-CoV-2 infection and management of infected patients involve the detection of viral RNA, but the presence of infectious virus particles is unknown. Viability PCR (v-PCR) uses a photoreactive dye to bind non-infectious RNA, ideally resulting in the detection of RNA only from intact virions. This study aimed to develop and validate a rapid v-PCR assay for distinguishing intact and compromised SARS-CoV-2. Propidium monoazide (PMAxx) was used as a photoreactive dye. Mixtures with decreasing percentages of intact SARS-CoV-2 (from 100% to 0%) were prepared from SARS-CoV-2 virus stock and a clinical sample. Each sample was divided into a PMAxx-treated part and a non-PMAxx-treated part. Reverse transcription-PCR (RT-PCR) using an in-house developed SARS-CoV-2 viability assay was then applied to both sample sets. The difference in intact SARS-CoV-2 was determined by subtracting the cycle threshold ( Ct ) value of the PMAxx-treated sample from the non-PMAxx-treated sample. Mixtures with decreasing concentrations of intact SARS-CoV-2 showed increasingly lower delta Ct values as the percentage of intact SARS-CoV-2 decreased, as expected. This relationship was observed in both high and low viral load samples prepared from cultured SARS-CoV-2 virus stock, as well as for a clinical sample prepared directly from a SARS-CoV-2 positive nasopharyngeal swab. In this study, a rapid v-PCR assay has been validated that can distinguish intact from compromised SARS-CoV-2. The presence of intact virus particles, as determined by v-PCR, may indicate SARS-CoV-2 infectiousness. IMPORTANCE This study developed a novel method that can help determine whether someone who has been diagnosed with coronavirus disease 2019 (COVID-19) is still capable of spreading the virus to others. Current tests only detect the presence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA, but cannot tell whether the particles are still intact and can thus infect cells. The researchers used a dye that selectively blocks the detection of damaged virions and free RNA. They showed that this viability PCR reliably distinguishes intact SARS-CoV-2 capable of infecting from damaged SARS-CoV-2 or free RNA in both cultured virus samples and a clinical sample. Being able to quickly assess contagiousness has important implications for contact tracing and safely ending isolation precautions. This viability PCR technique provides a simple way to obtain valuable information, beyond just positive or negative test results, about the actual risk someone poses of transmitting SARS-CoV-2 through the air or surfaces they come into contact with.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SARS-CoV-2COVID-19RNA, ViralReverse Transcriptase Polymerase Chain ReactionHumansCOVID-19 Nucleic Acid TestingPropidiumAzidesSensitivity and SpecificityCOVID-19 Testing

Stichwörter der Autor:innen

PMAxxSARS-CoV-2infectiousnessintact virus particlesviability PCRviral shedding

Substanzen

RNA, Viralpropidium monoazidePropidiumAzides

Autor:innen und Institutionen

  • University Eye Clinic Maastricht, Maastricht University Medical Center, Maastricht, the Netherlands.
  • School for Mental Health and Neuroscience (MHeNs), Maastricht University, Maastricht, the Netherlands.
  • Department of Medical Microbiology, Infectious Diseases & Infection Prevention, Maastricht University Medical Center, Maastricht, the Netherlands.
  • Care and Public Health Research Institute (CAPHRI), Maastricht University, Maastricht, the Netherlands.
  • Department of Clinical Chemistry and Hematology, Zuyderland Medical Center, Sittard-Geleen/Heerlen, the Netherlands.
  • School of Nutrition and Translational Research in Metabolism (NUTRIM), Maastricht University, Maastricht, the Netherlands.

ORCID-Profile: Judith M J Veugen, Bart L Haagmans, Mart M Lamers, Petra F G Wolffs

Förderung

  • ZonMw (Netherlands Organisation for Health Research and Development)

Zitieren

APA

Veugen, J. M. J., Schoenmakers, T., van Loo, I. H. M., Haagmans, B. L., Leers, M. P. G., Lamers, M. M., Lucchesi, M., van Bussel, B. C. T., van Mook, W. N. K. A., Nuijts, R. M. M. A., Savelkoul, P. H. M., Dickman, M. M., & Wolffs, P. F. G. (2024). Advancing COVID-19 diagnostics: rapid detection of intact SARS-CoV-2 using viability RT-PCR assay. Microbiology Spectrum. https://doi.org/10.1128/spectrum.00160-24

Vancouver

Veugen JMJ, Schoenmakers T, van Loo IHM, Haagmans BL, Leers MPG, Lamers MM, et al. Advancing COVID-19 diagnostics: rapid detection of intact SARS-CoV-2 using viability RT-PCR assay. Microbiology Spectrum. 2024. doi:10.1128/spectrum.00160-24

BibTeX
@article{Veugen2024,
  author = {Veugen, Judith M J and Schoenmakers, Tom and van Loo, Inge H M and Haagmans, Bart L and Leers, Mathie P G and Lamers, Mart M and Lucchesi, Mayk and van Bussel, Bas C T and van Mook, Walther N K A and Nuijts, Rudy M M A and Savelkoul, Paul H M and Dickman, Mor M and Wolffs, Petra F G},
  title = {Advancing COVID-19 diagnostics: rapid detection of intact SARS-CoV-2 using viability RT-PCR assay},
  journal = {Microbiology Spectrum},
  year = {2024},
  doi = {10.1128/spectrum.00160-24}
}
Kostenlos starten →